Found 455 matching trials
PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients
PHASE3This is a multicenter, randomized controlled, phase III clinical trial. The...
Location
Sun Yat-sen University Cancer Center
Conversion Therapy of Sintilimab in Combination With Apatinib and Chemotherapy in Stage IV Gastric Cancer
PHASE2This is a single-arm, phase II study aiming to evaluate the feasibility and...
Location
Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital
Study of SQZ-AAC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors
PHASE1This is a Phase 1 open-label, multicenter study of the safety and tolerabil...
Location
City of Hope Medical Center
Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer
PHASE1The goal of this clinical trial is to evaluate the efficacy and safety of c...
Location
Chinese Academy of Medical Sciences & Peking Union Medical College Hospital (CAMS&PUMCH)
Neoadjuvant Long-course Chemoradiation Plus PD-1 Blockade for Mid-low Locally Advanced Rectal Cancer
PHASE2This is a phase II/III, multi-center, open-label, 3-arm, randomized control...
Location
Beijing Friendship Hospital, Capital Medical University
PD-1, LAG-3 and TIM-3 Checkpoint Blockade in DLBCL
PHASE1This study is investigating the optimal dose and the advantage in combining...
Location
Multiple Locations
Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial
PHASE2This is a prospective, Bayesian adaptive, phase II clinical trial designed ...
Location
Cancer Center of Guangzhou Medical University
Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC
PHASE2This study is the study of the combination of PEGPH20 and Pembrolizumab (MK...
Location
Banner Health - MD Anderson Cancer Center
Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor
PHASE2The purpose of this research study is to see how useful it is to look at bi...
Location
Princess Margaret Cancer Centre
Gene-Modified Immune Cells (FH-MCVA2TCR) in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer
PHASE1This phase I/II trial studies the side effects of gene-modified immune cell...
Location
Fred Hutch/University of Washington Cancer Consortium